Shuttle Pharmaceuticals Reports Director/Officer Changes

Ticker: SHPH · Form: 8-K · Filed: May 28, 2025 · CIK: 1757499

Shuttle Pharmaceuticals Holdings, Inc. 8-K Filing Summary
FieldDetail
CompanyShuttle Pharmaceuticals Holdings, Inc. (SHPH)
Form Type8-K
Filed DateMay 28, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: leadership-change, corporate-governance

Related Tickers: SHPH

TL;DR

Shuttle Pharma (SHPH) filed an 8-K for director/officer changes as of 5/21.

AI Summary

Shuttle Pharmaceuticals Holdings, Inc. filed an 8-K on May 28, 2025, reporting events as of May 21, 2025. The filing indicates changes related to the departure of directors, election of directors, appointment of officers, and compensatory arrangements for certain officers. Specific details regarding the individuals involved, their roles, and the nature of the compensatory arrangements are not provided in this excerpt.

Why It Matters

Changes in a company's board of directors and executive officers can signal shifts in strategy, governance, or operational focus.

Risk Assessment

Risk Level: medium — Changes in key leadership roles can introduce uncertainty regarding future company direction and performance.

Key Players & Entities

  • Shuttle Pharmaceuticals Holdings, Inc. (company) — Registrant
  • May 21, 2025 (date) — Date of earliest event reported
  • May 28, 2025 (date) — Date of report
  • Delaware (jurisdiction) — State of incorporation
  • Gaithersburg, MD (location) — Principal executive offices

FAQ

What specific changes occurred regarding directors and officers?

The filing indicates the departure of directors, election of directors, and appointment of certain officers, but the specific names and details are not provided in this excerpt.

What is the effective date of the reported events?

The earliest event reported is dated May 21, 2025.

When was this 8-K form filed?

This 8-K form was filed on May 28, 2025.

What is the company's principal executive office address?

The principal executive offices are located at 401 Professional Drive, Suite 260, Gaithersburg, MD 20879.

What is the company's telephone number?

The registrant's telephone number is (240) 430-4212.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on May 28, 2025 regarding Shuttle Pharmaceuticals Holdings, Inc. (SHPH).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.